Home Compare BIM.PA vs GSK.L
Stock Comparison · Comparison

bioMérieux vs GSK: Which Stock Looks Stronger in 2026?

GSK holds the cleaner structural position, with the lead spread across profitability and stability. bioMérieux does not offset that deficit through any equally strong structural edge elsewhere. On the market side, GSK is in better shape — its trend is intact while bioMérieux's trend has broken down. That puts structure and market broadly in agreement — GSK's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the STOXX 600 universe, making them directly comparable.

Updated 2026-07-05

The lead is spread across profitability and stability, rather than sitting in one isolated gap. GSK plc leads by 24 points on the overall comparison score.

Trajectory Similarity
0.69
Moderately similar
Peer-set rank: #41
within bioMérieux S.A.'s functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

The pair shares a valid long-term profile match, but the trajectories are not especially close.

Most of the shared profile comes through recent revenue growth and capital structure.

Similarity drivers
recent revenue growthcapital structure
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
BIM.PA
bioMérieux S.A.
42
Peer-Score
Signal qualityMedium
Peer basis: STOXX 600
vs
GSK.L
GSK plc
66
Peer-Score
Signal qualitylow
Peer basis: STOXX 600

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: BIM.PA vs GSK.L Profitability 30 64 Stability 44 77 Valuation 62 83 Growth 25 31 BIM.PA GSK.L
Gap Ranking
#1 Profitability +34
#2 Stability +33
#3 Valuation +21
#4 Growth +6
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BIM.PA and GSK.L Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BIM.PAGSK.L Relative valuation Structural strength

GSK plc looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
On profitability, GSK plc is positioned higher in the group, while bioMérieux S.A. is closer to the middle.
Stability
Both profiles are strong on stability, but GSK plc leads clearly.
Profitability — Dominant Gap
BIM.PA
30
GSK.L
64
Gap+34in favour of GSK.L

The profitability lead is mainly driven by a 19.5-point operating margin advantage.

What else supports the lead

Stability also supports the lead, so the result is broader than one isolated gap.

What this means for the comparison

The lead is built on both profitability and stability, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the BIM.PA vs GSK.L comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-and-stability comparisons

Explore how BIM.PA and GSK.L each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.